Site Reference ID/Investigator# 46345 — Pell City, Alabama

Site Reference ID/Investigator# 46345 is a clinical research site located in Pell City, Alabama, United States 35128.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Site Reference ID/Investigator# 46345 has participated in 1 clinical trials.

Therapeutic areas: Chronic Kidney Disease, Diabetic Nephropathy.

Sponsors: AbbVie (prior sponsor, Abbott).

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Pell City

Browse all research sites in Alabama · View every site in Pell City

• Research Site
• Pfizer Investigational Site
• GSK Investigational Site
• Alabama Clinical Research Associates
• Novo Nordisk Investigational Site
• Furiex Research Site
• Forest Investigative Site 1353
• Advanced Clinical Research 1000 Forrest Place Suite 2 Pell City
• Teva Investigational Site 12130
• Advanced Clinical Research
• Research Center

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site Reference ID/Investigator# 46345?

Site Reference ID/Investigator# 46345 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site Reference ID/Investigator# 46345 conducted?

Site Reference ID/Investigator# 46345 has 1 clinical trials on record. Their work covers Chronic Kidney Disease, Diabetic Nephropathy.

Is Site Reference ID/Investigator# 46345 accredited by Crixeo Clinical Trials?

Site Reference ID/Investigator# 46345 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site Reference ID/Investigator# 46345?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.